Millennium Research and Clinical Development

Houston, Texas 77090

0 studies enrolling now · 4 studies all time

What they study most

Extensive Stage Small Cell Lung Cancer, Metastatic HER2-positive Breast Cancer, Metastatic Non-Squamous Non-Small Cell Lung Cancer, Non Small Cell Lung Cancer, Solid Tumor

Studies at this site

• A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer — Recruiting now
• Phase 3 Study of Sitravatinib Plus Nivolumab vs Docetaxel in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer — Completed
• To Evaluate Efficacy and Safety of Serplulimab + Chemotherapy (Carboplatin- Etoposide) in US Patients With ES-SCLC — Running, not enrolling
• SHP2 Inhibitor BBP-398 in Combination With Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer With a KRAS Mutation — Stopped early